Work

Supplementary Figure S7 from BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S7 shows the activation of human peripheral cDC1 cells by BCL2 inhibitors, as well as the in vivo migration of adoptively transferred cDC1 cells that were either WT, BCL2 inhibitor-treated or Bcl2 knock out.
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4388112104
Cites:
Cited by:
Related to: 10